Abstract Mesenchymal stem cell (MSC) aging seriously affects its function in stem cell transplantation for treatment. Extensive studies have focused on how to inhibit senescence in MSCs. However, the mechanism of senescence in MSC was not clear. In this study, we used D-galactose to induce MSC aging. Then we found that the number of aging cells was increased compared with untreated MSCs. We discovered that ascorbic acid could inhibit the production of reactive oxygen species (ROS) and activation of AKT/mTOR signaling in MSCs caused by D-galactose. Especially, when treated together with a ROS scavenger or AKT inhibitor, the senescent cells were obviously decreased in D-galactose-induced MSCs. Taken together, we identify that ascorbic acid owns the potential to inhibit the senescence of MSCs through ROS and Akt/mTOR signaling. Together, our data supports that ascorbic acid can be used to prevent MSCs from senescence, which can enhance the efficiency of stem cell transplantation in the clinic.
Introduction
Mesenchymal stem cells (MSCs) are important in selfrenewal and tissue-specific regeneration with advancing age. They have been an essential cellular source for stem cell treatment for a long time and are so far being tested in many ongoing clinical trials (Tsuchiya et al. 2017) . MSCs have been proven to own immunomodulatory effects on many activated immune cells, such as T cells, natural killer cells and B cells (Nauta and Fibbe 2007) . Moreover, because of their low immunogenicity and accompanying absence of expression of co-stimulatory molecules, MSCs have the ability to escape alloantigen recognition (Sun et al. 2007 ). Such properties make MSCs promising seeding cells for protecting against the rejection of certain organ transplants.
However, recent studies have found that MSC's function declines as the individuals age, thus leading to the dysfunction of MSC which influences the effects of autologous MSC transplantation in those individuals (Patel et al. 2013) . In recent studies it was also found that the MSC aging can be induced by old rat serum in recent studies (Mayack et al. 2010; Villeda et al. 2011 Villeda et al. , 2014 . So it is important to find an efficient method to delay MSC senescence in order to maintain the function of MSC transplantation.
As we all know, there are a variety of factors included in the process of cellular senescence. It is a complicated pathophysiological process, for instance the oxidative stress, shortening of telomere length, abatement of histone deacetylase and DNA methyltransferase and so on (Zhang et al. 2014) . It is critical that the balance between prooxidants and antioxidants can affect the survival of MSCs. ROS are not only the endogenous outcome of metabolism, but also the fundamental second messages in cellular signaling including cell cycle arrest and cell death. More and more evidence has accumulated to explain that intracellular ROS is the main factor resulting in cellular aging. Excessive ROS accumulation could harm cellular proteins and DNA which could result in cellular senescence and even the death of cell. Studies have been done to prove that excessive activation of Wnt/b-catenin signaling has something to do with MSC aging induced by ROS (Wang and Tan 2013; Zhang et al. 2013) . It is believed that inhibiting the senescence of cell can recover cell viability and MSC function. So the most important thing to do is to seek safe and effective antioxidants that inhibit the oxidative damage and cellular senescence induced by ROS.
Ascorbic acid works as a cofactor in many biological processes. At particular concentration, ascorbic acid works as a growth promoter to promote proliferation when supplied to the culture medium (Choi et al. 2008) . However, when at elevated concentration elevated ascorbic acid can be cytotoxic resulting in apoptosis and proliferation inhibition. Ascorbic acid is a naturally effective antioxidant. It can clean up ROS effectively. AKT and mammalian target of rapamycin (mTOR) signaling pathways have been found to be associated with stem cell aging. We also found that there are connections between Akt/mTOR signaling and ROS. Both of the pathways can impact each other (Maiese et al. 2012) . Increasing ROS generation correlates with the high levels of mTOR. Thus, we need to clarify whether ascorbic acid can retard MSC senescence through AKT/mTOR pathway.
Although ascorbic acid has been found to accelerate the growth of MSC, the molecular mechanisms and main effect by which ascorbic acid modulates stem cell aging are still unknown. In this article, for the first time we clarify that ascorbic acid can retard the senescence of MSC through AKT/mTOR signaling pathway.
Materials and methods

Isolation and culture of BMSCs
Seven-day-old Sprague-Dawley (SD) rats were obtained from the experimental animal center of Shanghai Jiao Tong University. The investigation was allowed by the law of the People's Republic of China on the protection of wildlife and the protocol was approved by Shanghai Medical Academy of Science, China. SD rats' femurs and tibias were removed and the bone marrow was flushed out with blank medium. The cells were centrifuged at 1000 rpm for 3 min. The cell was resuspended in 5 ml Dulbecco's modified Eagle's medium (DMEM, Gibco, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS, Gibco) and penicillin (100 U/ml)/streptomycin (100 U/ml) at 37°C in humid air with 5% CO 2 and then plated in a 25 cm 2 plastic flask (Corning, USA) to let the MSCs adhere. Three days later, the medium was changed and the nonadherent cells were discarded. Fresh medium was changed every 3 days. After about 7-10 days, the adherent cells were released from the flask with 0.25% trypsin (Gibco) and seeded into new fresh culture flasks. They were marked as passage 1 and cells were continued to be cultured until passage 3. All experiments described below were performed using cells of the 3rd passage.
Cell counting Kit-8 assay BMSCs plated in 96-well plates were treated with Dgal at different doses and time points. Cell viability was assessed by the Cell Counting Kit-8 assay (CCK-8; Dojindo, Kumamoto, Japan) following the manufacturer's protocol.
Cell culture and D-gal treatment BM-MSCs were cultured in growth medium at 37°C with 5% CO 2 in 175 cm 2 cell culture flasks. Medium was changed every 3 days. Cells were dissociated by 0.25% trypsin-EDTA and reseeded into 6 cm plates for the next stage of the experiments. In order to induce premature senescence, BM-MSCs at approximately 70% confluence were exposed to 1, 10, and 100 g/l of D-gal (Gibco) for 48 h.
Treatments with ascorbic acid BM-MSCs were pretreated with 200 lmol/l ascorbic acid (Gibco) for 2 h followed by co-exposure to 10 g/l D-gal and ascorbic acid for the next 48 h.
SA-b-gal staining
The expression of senescence-associated b-galactosidase (SA-b-gal) in BMSCs has been used as a typical biomarker of premature senescence. SA-b-gal staining was performed by using a SA-b-gal staining kit (Cell Signaling Technology, Beverly, MA, USA) following the manufacturer's instructions. The cells were incubated at 37°C without CO 2 overnight. The number of positive cells was counted using a phase-contrast microscope and the experiment was repeated five times in each group.
Detection of ROS level
Intracellular ROS staining was performed using a DCFH-DA staining kit (Genmed, Plymouth, MN, USA), according to the manufacturer's protocol. BMSCs were treated with fluorescent probes DCFH-DA (1:1000) and then incubated at 37 C for 20 min after washing with serum-free medium. The cells were observed using a fluorescence microscope (Eclipse 50I, Nikon, Tokyo, Japan) under 488 nm excitation wavelength and 525 nm emission wavelength in order to quantify the ROS level. Experiments were repeated five times.
Western blot analysis
Cells samples were lysed in ice-cold RIPA including protease inhibitor cocktail (Sigma-Aldrich) for 30 min. Then the lysates were centrifuged at 12,500g for 15 min 4°C and the supernatant was collected. The protein concentration was quantified with a Pierce BCA protein assay kit (Thermo Scientific, Fremont, CA, USA), according to the manufacturer's instruction. Equivalent amounts of protein were loaded and separated by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA, USA). Membranes were incubated with horseradish peroxidase-(HRP)-conjugated anti-rabbit or anti-mouse secondary antibodies (1:2000, Dako, Carpinteria, CA, USA), and proteins were detected by enhanced chemiluminescence (ECL) (Amersham Biosciences Corp., Pittsburgh, PA, USA).
Statistical analysis
Data are presented as mean ± SD. Significance testing was performed using one-way analysis of variance (ANOVA) to compare data from different experimental groups. Statistical values were calculated using the SPSS 19.0 software and illustrated using the GraphPad Prism 5.0. Differences with a value of P \ 0.05 were regarded as statistically significant.
Results
D-Gal induced cellular senescence in BMSCs in vitro
In order to detect the particular dose and action time of D-gal, the cell survival rate was measured by CCK-8. BMSCs were treated with D-gal at different doses (1, 10, 100 g/l) and time points (6, 12, 24, 48, 72 h ). The relative cell number was measured to evaluate the cell growth. We found that cell survival rate was inhibited by D-gal in a time-and dose-dependent manner. According to the survival curve ( Fig. 1) , according to the IC 50 and the obvious downward trend, induction by 10 g/l D-gal for 48 h could be applied in the followup experiments.
Ascorbic acid retards D-gal-induced MSCs senescence
Two major signaling pathways are involved in senescence: the p53/p21 and the p16
INK4a
/CDK/pRb pathways (Kailong et al. 2007 ). Here, we simply examined p16
INK4a protein expression to evaluate cellular senescence. The expression of p16 was gradually increased as the concentration raised (Fig. 2a) . Comparison with the control group was clear enough. We next chose different time point to confirm the effect of D-gal to induce the aging of BMSCs. The expression of p16 was time dependent (Fig. 2b) . However, the increased expression of p16 induced by D-gal could be reduced when treated with ascorbic acid (AA) (Fig. 3a) . The technique of SA-b-gal staining was performed to examine aging cells. We found that SA-b-gal positive cells ratio was obviously increased by D-gal stimulation. After adding AA, this ratio could be decreased compared to D-gal only group (Fig. 3b) .
The role of ROS/mTOR signaling pathway and ascorbic acid in D-gal-induced senescence ROS and AKT/mTOR signaling pathways are involved in a variety of physiological processes, including cellular senescence (Schieber and Chandel 2014) . In this study, we intend to determine the significance of ROS/mTOR signaling pathway in cellular senescence and the correlation between each other in this process. ROS can be induced by D-gal and D-gal has been used in many animal models in order to make aging models (Dong et al. 2017 ). So we used D-gal to stimulate BMSCs and check the change of ROS and the activation of AKT/mTOR signaling pathway. As we forecasted before, ROS fluorescence was enhanced by D-gal, and AA could weaken the ROS change (Fig. 4) . The expressions of p-AKT and p-mTOR were promoted by D-gal in a timeand dose-dependent manner (Fig. 5a, b) . Activation of AKT/mTOR signaling pathway was increased in the Dgal group, and weakened when AA was added (Fig. 5c ). As we discussed earlier, D-gal can induce cellular senescence, and AA was able to block the progress. The trend of ROS generation and Akt/mTOR signaling pathway change matches with cellular senescence stimulated by D-gal and AA. We have the reason to say that ROS and AKT/mTOR signaling pathway play important roles in D-gal-induced cellular senescence. We analysed the expression of p16 and the SA-b-gal of BMSCs to confirm these findings. We used N-acetylcysteine to inhibit ROS signaling pathway, and found that the generation of ROS was decreased along with the reduced number of cells (Fig. 6a, b, d) . According to the expression of p-AKT and p-mTOR, we found that the activation of mTOR signaling pathway was decreased, too (Fig. 6c) . We next inhibited the AKT signaling pathway with GSK690693. The cellular aging induced by D-gal was also decreased, just like the N-acetylcysteine did (Fig. 7b, d) . Meanwhile, activation of mTOR signaling pathway was weakened without the change of ROS generation (Fig. 7a, c) . Then we inhibited the mTOR signaling pathway with Rapamycin. We also could find that cellular aging induced by D-gal was decreased without the change of ROS generation (Fig. 8) .
Discussion
In the present study, we examined the effects and underlying mechanisms of AA on D-gal-induced premature senescence in MSCs. Our results demonstrated that treatment with AA can reverse cellular senescence and that AA-mediated anti-senescence effects involve the activation of the ROS and Akt/ mTOR pathway.
MSCs possess a self-renewal ability and can differentiate into cells of multiple lineages (Goerke et al. 2012; Wakao et al. 2012) , which seem to be a large therapeutic promise in clinical cell transplantation therapy (Abdallah and Kassem 2008; Mohammadian et al. 2013) . However, many studies have shown that senescence of MSCs influences the effect of their clinical application (Raggi and Berardi 2012; Yu and Kang 2013; Zhang et al. 2011) . Although the exact mechanisms of cellular senescence are still indeterminate, ''the free radical theory of aging'' has been widely accepted (Harman 2006) . In MSCs, excess ROS can impair self-renewal, differentiation capacity, and proliferation (Denu and Hematti 2016; Mohtasebi et al. 2014; Tan and Suda 2017) . The increasing accumulation of free radicals can harm most of the biomolecules, including DNA, protein, and lipids. High ROS levels may cause cellular damage and dysfunction, leading to the senescence of the cell (D'Apolito et al. 2017; Salazar et al. 2017 ). Many researches have proven that D-gal-induced mouse can be used as an experimental model for researching aging Xie et al. 2012 ). Especially, there were studies having proven that the mechanism of D-gal induced MSC aging was mainly through promoting ROS generation (Hu et al. 2015) . In our experiment, we have found that the number of SA-b-gal-positive MSCs in 10 g/l D-gal group was obviously increased.
Ascorbic acid (AA) is a powerful antioxidant that mediates several beneficial effects on redox oxidative pathways (Gegotek et al. 2017) . Several recent studies have shown that AA owns an important protective ability to protect cells from apoptosis, such as in skin and hair, chondrocytes and fibroblasts (Chang et al. 2015; Wakame et al. 2017) . However, it is still unclear if AA plays a role in the senescence of stem cells. This is the first time we have discovered that AA can delay the senescence of mesenchymal stem cells through ROS and AKT/mTOR signaling.
The present study found that the main mechanism of the protective effects of AA on cellular aging was that it could decrease the oxidative stress. Yet, ROS is connected with many intracellular pathways (Maiese et al. 2012; Wang et al. 2014) . Some of these signaling pathways are involved in the cellular senescence (Bishayee et al. 2013) . The AKT/mTOR pathway is one of the pathways which plays an important part in the aging of the cells (Castilho et al. 2009; Li et al. 2013) , and in cancer cells this pathway has been proven that it has relation to ROS pathway (Shin et al. 2013) . Also, there is evidence that inhibition of this pathway may extend the lifespan of many species (Harrison et al. 2009 ). Researcher showed that active AKT inhibits the transcriptional activity of FOXO3a and down-regulates MnSOD, resulting in an increased level of ROS that induced cellular senescence (Xu et al. 2014) . Therefore, we hypothesized that AKT/ mTOR signaling inactivation was the reason why AA inhibited MSC senescence induced by D-gal. We measured the ROS and the protein expressions of p-AKT and p-mTOR to ensure the activation of ROS and AKT/mTOR signaling pathway. In this process, we found that there was the same trend between the activation of ROS/AKT/mTOR signaling pathway and the increased senescence. As the senescence cells increased, we found the ROS increased and AKT/mTOR signaling pathway activated. Then we used the inhibitor to block the ROS or AKT/mTOR signaling pathway, we found the number of senescent cells was decreased, too. Thus we confirmed that the ROS and AKT/mTOR signaling pathway had something to do with the cellular aging. We also detected that the number of senescent cells and the activation of mTOR signaling pathway were clearly different between the D-gal group and the D-gal ? AA group after blocking ROS; also there were important differences between the D-gal group and the D-gal ? AA group in senescence after blocking AKT.
The mechanism of D-gal which causes cellular senescence is mostly the excessive ROS production. In this experiment, we confirm that D-gal can affect the production of ROS. At the same time, we investigated b Fig. 7 the connection between D-gal and AKT/mTOR signaling pathway. By testing the p-AKT and p-mTOR, we found that D-gal could affect the activation of mTOR signaling pathway at the same time. However, the AKT inhibitor can reduce the cellular senescence induced by D-gal. We confirm that the AKT/mTOR signaling pathway is involved in the mechanism of Dgal-induced senescence. Our study has found the effect of ascorbic acid on senescence. However, the specific mechanism is not explicit. Da Silva et al. (2017) found the inhibition effect of Ascorbic acid on oxidative stress. Kashino et al. reported that AA had protective effects against cellular senescence via scavenging ROS (Kashino et al. 2003) . In our study, we found that ascorbic acid could affect ROS, which was in line with previous studies. Meanwhile, we also studied the link between AA and AKT/mTOR signaling pathway. By detecting the change of p-AKT and p-mTOR, we found that AA could affect the activation of mTOR signaling pathway. By blocking AKT, the function of AA can be affected. Thus the effect of antisenescence of ascorbic acid may have close association with AKT/mTOR signaling pathway.
Although ROS and AKT/mTOR signaling pathways have an important effect on D-dal-induced aging, there were no explicit quantified standards for us to explore the particular points D-gal and AA worked on. Thus, more studies need to be performed.
Conclusion
In conclusion, D-gal can induce the MSC aging through promoting ROS generation. Ascorbic acid can obviously decrease the number of SA-b-galpositive cells and the expression of p16 in D-galtreated MSCs. Ascorbic acid may be an effective protection agent of stem cell senescence induced by ROS. The AKT/mTOR signaling may be the main mediator of ascorbic acid inhibiting MSC senescence. Further deeper studies of the mechanisms of ascorbic acid involved in stem cell aging will help extend the clinical applications and improve the clinical value of ascorbic acid.
